New cheerleader, same tiny stock
Kraken Robotics just picked up a buy rating, and the thesis reads like a classic growth-stock starter pack: strong revenue guidance, improving margins, and a sector backdrop that’s doing it a lot of favors.
The company is now talking up 2026 revenue of C$170 million, which would be a 67% year-over-year jump. That’s not “nice progress.” That’s “someone just hit the turbo button” territory, especially for a smaller defense-and-commercial tech name.
Why investors are leaning in
The bull case isn’t just about top-line growth. The argument is that Kraken’s business is getting better quality, too:
- Defense and commercial demand are both helping fill the pipeline
- Margin expansion suggests the company may be getting more efficient as it scales
- The Covelya acquisition is expected to broaden product offerings and widen the customer base
That acquisition also comes with a price tag of 9.7x 2025E adjusted EBITDA, which is the kind of number that makes M&A people nod thoughtfully and everyone else squint a little. The hope is that it’s accretive and creates operational synergies instead of becoming an expensive trophy on the balance sheet.
Big picture
For investors, this is the fun part of the small-cap growth game: if the guidance is real and the acquisition lands cleanly, Kraken could keep building momentum. If not, you know the drill — the stock can go from hero to headache pretty quickly.
Big picture: the market loves a company with a growth story, a stronger margin story, and a little M&A spice on top. Kraken just got all three.